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MicroRNA (miRNA)-guided messenger RNA (mRNA) translational repression is believed to be mediated by eﬀector miRNA-
containing ribonucleoprotein (miRNP) complexes harboring fragile X mental retardation protein (FMRP). Recent studies docu-
mented the nucleic acid chaperone properties of FMRP and characterized its role and importance in RNA silencing in mammalian
cells. We propose a model in which FMRP could facilitate miRNA assembly on target mRNAs in a process involving recognition
of G quartet structures. Functioning within a duplex miRNP, FMRP may also mediate mRNA targeting through a strand exchange
mechanism, in which the miRNA∗ of the duplex is swapped for the mRNA. Furthermore, FMRP may contribute to the relief of
miRNA-guided mRNA repression through a reverse strand exchange reaction, possibly initiated by a speciﬁc cellular signal, that
would liberate the mRNA for translation. Suboptimal utilization of miRNAs may thus account for some of the molecular defects
in patients with the fragile X syndrome.
Copyright © 2006 I. Plante and P. Provost. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
THE miRNA-GUIDED RNA SILENCING
MACHINERY AND DISEASES
MicroRNAs (miRNAs) are small ∼21- to 24-nucleotide (nt)
RNAs that mediate messenger RNA (mRNA) translational
repression through recognition of speciﬁc partially comple-
mentary binding sites usually located in the 3  nontranslated
region (NTR). They are generated by successive process-
ing of stem-loop structured primary miRNAs (pri-miRNAs)
and miRNA precursors (pre-miRNAs) by the ribonucleases
(RNases) III Drosha [1]a n dD i c e r[ 2–4], respectively, as re-
viewed in this issue by Ouellet et al [5]. Encoded by 1–5% of
the genome in eukaryotes, miRNAs may regulate more than
30% of the genes in humans [6, 7]!
Unveiling the complexity of the process, recent studies
haveidentiﬁednewproteincomponentsinvolvedinmiRNA-
guided RNA silencing, such as DiGeorge syndrome critical
region 8 (DGCR8) [8–11], transactivating response (TAR)
RNA-binding protein (TRBP) [12–15], and fragile X men-
tal retardation protein (FMRP) [16, 17]. Intriguingly, these
accessory proteins, which are required for optimal function-
ing of the pathway, are related to speciﬁc human diseases.
Thus, in addition to the emerging causal links between de-
fective miRNAs and human diseases, as reviewed in Ouellet
et al [5]a n dP e r r o ne ta l[ 18], some genetic disorders might
also be related to malfunctioning of the machinery involved
in miRNA biogenesis and function.
DGCR8 was identiﬁed in Drosha immunoprecipitates
and found to be required for optimal pri-miRNA process-
ing [10]. Both acting within the Microprocessor complex
[10], DGCR8 has been proposed to guide Drosha in sub-
strate recognition [11]. Clinically, patients carrying a com-
mon monoallelic deletion aﬀecting the DGCR8 gene dis-
play phenotypes deﬁned as the DiGeorge syndrome, with
manifestationssuchascongenitalheartdefects,characteristic
facial appearance, immunodeﬁciency, and behavioral prob-
lems [19, 20]. The possibility that the DiGeorge syndrome is
caused by a perturbed Drosha function and/or pri-miRNA
processing is attractive, but remains to be established.
As for TRBP, it was identiﬁed by proteomic analysis of
Dicer immunoprecipitates and reported to assist Dicer func-
tion within a pre-miRNA processing complex [12, 13]. Ini-
tially identiﬁed in 1991, TRBP was characterized as a cellu-
lar factor acting in synergy with the viral Tat protein in the2 Journal of Biomedicine and Biotechnology
transactivation of the long terminal repeat of human im-
munodeﬁciency virus type 1 (HIV-1), leading to viral gene
transcription [21]. TRBP may thus play a dual role in HIV-1
pathogenesis and RNA silencing, as recently discussed [22].
Two independent groups simultaneously reported a pos-
sible relationship between the Drosophila FMRP ortholog
(dFMR1) and RNA interference (RNAi). dFMR1 was found
to be associated with the eﬀector RNA-induced silencing
c o m p l e x( R I S C )a sw e l la sm i R N A si nDrosophila S2 cells
[16, 17]. In mammalian cells, FMRP was reported to be part
of a ribonucleoprotein (RNP) complex with Argonaute 2
(Ago2) and miRNAs [23]. These ﬁndings suggest a possible
link between the loss of FMRP function in miRNA-guided
RNA silencing and the fragile X syndrome.
FMRP AS A REGULATOR OF TRANSLATION
In humans, the FMR1 (fragile mental retardation 1) gene,
which spans ∼38kb in the q27.3r e g i o nl o c a t e da tt h et i po f
the X chromosome long arm, encodes an mRNA of ∼3.9kb
composed of a ∼0.2kb 5 N T R ,a1 .9kb coding region, and a
1.8kb3  NTR [24]. Loss of the FMR1 gene product FMRP is
the etiologic factor of the fragile X syndrome, the most fre-
quentcauseofinheritedmentalretardation[25,26].Itaﬀects
about 1 in 4000 males, who will develop in almost all cases
moderate to severe mental retardation (IQ ≤ 50), and about
1 in 7000 females, who present in general a milder mental
handicap [24].
FMRP has been detected in practically every tissue in
humans and rodents, with high levels in the brain, testes,
esophagus, lung, and kidney [27]. The ability of FMRP to
bind RNA, which was ﬁrst suggested by the presence of K-
homology (KH) domains and an RGG box found in various
RNA-binding proteins, was later conﬁrmed experimentally
[28, 29]. FMRP is associated with translating polyribosomes
inneuronalcells[30,31]andacts,athighlevels,asanegative
regulator of translation in vitro and in vivo [32–34].
Experimental studies have documented the involvement
of FMRP in translational control. When preincubated with
mRNAs, FMRP leads to inhibition of translational inhibi-
tion both in vitro in the rabbit reticulocyte lysate system and
in vivo after microinjection in the Xenopus oocytes [32, 33].
In Drosophila, the dFMR1 protein was reported to down-
regulate expression of the futsch protein [35]. Expression of
high levels of FMRP results in repression of reporter genes in
transfected cultured mammalian cells [34]. Although FMRP
hasbeenshowntointeractwithmRNAsandtoinhibit trans-
lation, its exact role and function are unclear.
More recently, using the recombinant protein, Gabus et
al [36] have shown that FMRP possesses nucleic acid chaper-
one properties, shedding new light on the principal mecha-
nism by which FMRP could regulate gene expression. They
observed that FMRP could either anneal or transfer DNA
strandsofTARthatareperfectlycomplementaryinvitro.Ex-
amining these activities in a hammerhead ribozyme model
system, the authors noted that FMRP enhanced ribozyme
cleavage of an RNA substrate. The KH motifs and RGG box
were found to be important for optimal chaperone activity
miRNA
Target mRNA
miRNA:miRNA
￿
1
2
FMRP
miRNA:mRNA
assembly
FMRP
miRNA
￿/mRNA
strand exchange
miRNA:mRNA
miRNA:mRNA
+
miRNA
￿
Figure 1: FMRP can assemble and exchange strands of RNAs in-
volved in miRNA-guided RNA silencing. Recombinant FMRP can
(1) assemble an miRNA to its speciﬁc mRNA target, or (2) use
an miRNA:miRNA∗ duplex for mRNA targeting through an RNA
strand exchange reaction, which releases the miRNA∗.
[36]. These ﬁndings suggest that FMRP may regulate trans-
lation by acting on the structural status of mRNAs.
Are these nucleic acid chaperone properties of FMRP
compatiblewith,andrelevantto,aspeciﬁccellularcontextor
regulatory process, such as miRNA-guided RNA silencing?
A ROLE FOR FMRP IN miRNA-GUIDED RNA SILENCING?
In Drosophila S2 cells, mRNA-cleaving RNP complexes have
been found to contain dFMR1 [16, 17]a sw e l la sas i n -
gle siRNA strand [37, 38]. Independent groups have shown
that target cleavage directed by single-stranded (ss) siRNAs
i ss u p p o r t e di ne x t r a c t so fH e L ac e l l s[ 39, 40], from which a
human RISC containing ss siRNAs was characterized [40].
In mammalian cells, FMRP was reported to be part of an
miRNA-containingRNP(miRNP)complexcontainingAgo2
[23]. Thus, although the mammalian and ﬂy RNA-silencing
machineries diﬀer substantially, they may share two features
in common: an RNP complex containing an ssRNA species
and a member of the fragile X family of proteins.
HowmiRNAsandsssiRNAsareusedbytheeﬀectorRNP
complexes for recognition and targeting of regulatable mR-
NAs remains poorly understood. However, rather than being
the result of a passive hybridization reaction, formation of
an miRNA:mRNA or ss siRNA:mRNA transition complex is
more likely to be facilitated by a component of the miRNP
or siRNP complexes. Capable of promoting RNA folding
andhybridization,FMRPrepresentsthemostinterestingand
valuable protein candidate.
FMRP FACILITATES miRNA ASSEMBLY ON
TARGET mRNA
We veriﬁed this possibility and showed that human FMRP
can act as an miRNA acceptor protein for Dicer and facili-
tate assembly of miRNAs on speciﬁc target RNA sequences
(see Figures 1 and 2)[ 41]. In these assays, FMRP exhibited a
preference for assembling imperfectly paired miRNA:mRNA
duplexes, which is the most prevalent situation encountered
in mammals. The miRNA assembler property of FMRP wasI. Plante and P. Provost 3
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Figure 2: Proposed roles and functional regulation of FMRP in miRNA-guided RNA silencing. (1) mRNA targeting by mature miRNPs
may involve the concerted assembly of the miRNAs to their binding sites with the recognition of G quartet structures in speciﬁc mRNAs
by FMRP (in purple). Acting within miRNPs, FMRP may play a key role by relieving translational repression through disassembly of the
miRNA:mRNA complexes. mRNAs repressed by miRNPs could thus be reutilized and translated into proteins. This process may be triggered
byacellularsignal,possiblyadephosphorylationevent. Avariantofthatphenomenon wouldhaveacomplementaryRNA,likethemiRNA∗,
involved in a strand exchange reaction making the mRNA available for translation, while recycling the miRNP into a duplex miRNA-
containing RNP. (2) In the absence of FMRP, miRNA assembly on target mRNAs may be suboptimal. Moreover, FMRP-deﬁcient miRNPs
may be less responsive to signal-induced miRNA:mRNA disassembly, resulting in a suboptimal dissociation from the target mRNAs. In
certain tissues where it is expressed, the FXR1P paralog (in orange) may functionally complement, and possibly compensate for, the absence
or loss of FMRP expression.
abrogated upon deletion of its RNA-binding KH domains
[41]. In line with these ﬁndings, reporter gene silencing as-
says supported the involvement of FMRP in an ss siRNA-
containing RNP (siRNP) eﬀector complex and revealed its
requirement for optimal RNAi in cultured mammalian cells
[41]. These data suggest that FMRP may function as the
miRNA assembler in RNA silencing.
FMRP CAN EXCHANGE miRNA∗/mRNA STRANDS
Recently, native gel electrophoresis unveiled diﬀerent RNP
complexescontainingsiRNAduplexesinDrosophila[37,38],
leading the authors to propose a siRNP assembly scheme
compatible with conversion of double-stranded (ds) siRNP
into ss siRNP. mRNA cleavage activity could only be corre-
lated with the latter complex [37]. siRNA-induced mRNA
cleavage and miRNA-guided translational repression may be
mediated by diﬀerent RNP complexes and diﬀer mechanis-
tically. If ss siRNPs induce mRNA cleavage, what about the
complexes that mediate inhibition of translation? Do they
contain ssRNA or dsRNA, such as miRNA duplexes? In fact,
duplex RNA-containing RNPs may be more than precur-
sors of ssRNA-containing RNPs. They may be functionally
important in RNA silencing. Whether they are involved in
miRNA-guided translational repression has not been ad-
dressed so far.
However, this would require resolution of the “three-
strand” enigma, posed by targeting of an ssRNA by
dsRNA species. In that context, formation of a speciﬁc
miRNA:mRNA transition complex from a miRNA:miRNA∗
duplex and its target RNA would appear as obligatory. In-
terestingly, human FMRP can do just that! We observed
that FMRP can accept and utilize miRNA:miRNA∗ du-
plexes, generated upon Dicer processing of pre-miRNAs,
to favor miRNA:mRNA complex formation through an
miRNA∗/mRNA strand exchange reaction [41], as illus-
trated in Figure 1. Together, these observations suggest that
FMRP could facilitate mRNA targeting by acting (i) as
an miRNA assembler in ssRNA-containing RNPs, and (ii)
as an miRNA∗/mRNA strand exchanger in duplex RNA-
containing RNP eﬀector complexes.
IS FMRP INVOLVED IN RELIEVING mRNA REPRESSION?
Reversibility is a fundamental diﬀerence between siRNP-
mediated mRNA cleavage or miRNP-guided translational
repression. If mRNA structural and functional integrity
is preserved, silenced mRNAs could be translated again,4 Journal of Biomedicine and Biotechnology
whereasdegradedmRNAscouldnot.InDrosophila,theRISC
mediates cleavage of the mRNA target, and is presumably
regenerated, allowing for repeated cycles of mRNA inacti-
vation and ampliﬁcation of the phenomenon [43]. In con-
trast to the most prevalent situation in ﬂies and plants,
mammalian mRNAs are mainly and primarily subjected to
miRNP-induced translation repression prior to their reloca-
tion to speciﬁc cytoplasmic foci, referred to as processing (P-
bodies) [44, 45] or GW182-containing bodies (GW-bodies)
[46], where mRNA degradation occurs. This sequence of
events is supported by a recent study revealing that mRNAs
containing partial miRNA complementary sites are eventu-
ally targeted for degradation in vivo, as exempliﬁed by the
lin-41 mRNA:let-7 miRNA tandem [47].
Do P-bodies represent the unique and ultimate destina-
tionofmiRNA-repressedcellularmRNAs?CanthesemRNAs
be prevented from reaching their ﬁnal destination? Is there a
deﬁned structural or functional point of no return, ahead of
which mRNAs could be redirected towards the translation
machinery? Most interestingly, can mRNAs escape and re-
turn “safe” from P-bodies and be used again for protein syn-
thesis? In these cases, the involvement of a protein having the
ability to shuttle between cellular compartments may be ex-
pected.
miRNPs may be perceived as translational “locks” and
contribute to preserve mRNA structural and functional in-
tegrity until it needs to be translated again. Relief of the
miRNA-guided translational repression may thus represent a
posttranscriptionalcontrolofgeneexpressionrelevanttosit-
uations where speciﬁc proteins need to be expressed within
minutes under speciﬁc circumstances, such as conditions
of cellular stress. The exact mechanism and duration of
miRNA-inducedrepressionofagivenmRNAremainunclear
at this point. As well, no information is currently available as
to how long the mRNA can be stored when complexed with
m i R N P s .H o w e v e r ,i fm i R N Ar e p r e s s i o no fm R N A sc a nb e
relieved, it would likely involve a coordinated and regulated
disassemblyofmiRNA:mRNAcomplexes,aprocessprobably
executed by a component of miRNPs, such as FMRP.
FMRP MAY ACT AS A MOLECULAR SWITCH IN
miRNA-GUIDED RNA SILENCING
How could miRNA repression be relieved? It may be ini-
tiated upon destabilization of miRNP binding to the re-
pressed mRNA, induced by unknown cellular signals or fac-
tors, leading to dissociation of the miRNA:mRNA complex
(see Figure 2). Whether diﬀerences in strand complementar-
ity of the complexes can contribute or suﬃce to drive this
reaction backward requires further investigation.
Alternatively, the RNA strand exchange properties of
FMRP may participate to the relieving of miRNA repres-
sion,inareactionpossiblyinvolvingthemiRNA∗,whosefate
and function remain obscur. A recent study by Matranga et
al [48] showed that the siRNA passenger strand of the du-
plex is cleaved by Ago2 in Drosophila embryo lysates. How-
ever, the authors showed that passenger-strand cleavage is
not important for the incorporation of miRNAs that derive
frommismatchedduplexes[48].Theseobservationsraisethe
following question: do miRNAs∗ play a signiﬁcant role in
RNA silencing?
The possibility that the miRNA∗ could be used by FMRP
like a spare RNA for the mRNA to be relieved from the
miRNA repression, as illustrated in Figure 2, is plausible
and attractive. Characterized as a chaperone [36], FMRP
could bind to one or more nucleic acid molecules and pro-
mote the formation of the most stable structure, upon which
its continued binding is no longer required to maintain it
[36, 49, 50]. The results of our previous study [41] sug-
gest that the miRNA:mRNA complex is more stable than the
miRNA:miRNA∗ duplex. We hypothesize that unknown cel-
lularsignalsorfactorsmayassistFMRPinexecutingareverse
strand exchange by lowering the required thermodynamic
threshold.ThemiRNA∗ mayfurtherfacilitatethatprocessby
providing an appropriate sequence-speciﬁc RNA template.
The reaction would liberate the mRNA for translation and
lead to reconstitution of a duplex miRNP, theoretically avail-
able for subsequent rounds of mRNA regulation events.
A ROLE FOR FMRP DEPHOSPHORYLATION IN
RNA SILENCING?
FMRP may function as a molecular device regulating mRNA
translation by allowing optimal miRNA assembly or dis-
assembly in response to speciﬁc cellular signals or fac-
tors. Posttranslational modiﬁcations, such as phosphoryla-
tion/dephosphorylation events, may regulate FMRP func-
tion in RNA silencing, allowing it, for example, to switch
between the forward (on) and reverse (oﬀ)m o d e so fR N A
strand exchange. Drosophila FMR1 is phosphorylated by ca-
sein kinase II at serine 406 (Ser406), which is highly con-
served among fragile X family members from several species
[51]. This residue is located in close proximity to the RGG
box and corresponds to Ser499 [52] or Ser500 [51]( d e -
pending on amino acid numbering) in human FMRP, which
was also found to be phosphorylated in vivo. Phosphoryla-
tionupregulateddFMR1oligomerization,therebyenhancing
the RNA-binding properties of the protein [51]. In contrast
to the Drosophila ortholog, the phosphorylation status of
mammalianFMRPdidnotinﬂuenceitsassociationwithspe-
ciﬁc mRNAs in vivo [52]. The authors, however, found that
unphosphorylated FMRP is associated with actively trans-
lating polyribosomes, while a fraction of phosphorylated
FMRP is associated with apparently stalled polyribosomes
[52]. These data suggest that the release of FMRP-induced
translational suppression may involve a dephosphorylation
signal [52].
FMRP MAY BE A KEY DETERMINANT OF
miRNA:mRNA SPECIFICITY
The presence and importance of FMRP in eﬀector miRNP
complexes may explain why FMRP is found associated with
several hundreds of diﬀerent mRNAs [53]. It will be interest-
ing to see what proportion of these mRNAs bound by FMRP
[53, 54] is experimentally validated and physiologicallyI. Plante and P. Provost 5
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Figure 3: A potential role for suboptimal miRNA:mRNA assembly and/or disassembly in the etiology of the fragile X syndrome. (1) miRNA
assembly on target mRNAs may be optimal when facilitated by FMRP, which may also be required for optimal relief of miRNA-guided
translational repression. (2) In the absence of FMRP, suboptimal miRNA assembly on target mRNAs may lead to overexpression of speciﬁc
proteins. (3) Whereas suboptimal disassembly of FMRP-deﬁcient miRNPs from target mRNAs may result in a prolonged inhibition of trans-
lation. The resulting misbalanced expression of miRNA-regulated genes may alter downstream cellular processes and metabolic pathways
(not depicted in this ﬁgure) and lead to the development of the fragile X syndrome.
relevant miRNA targets. Using a bioinformatic approach,
John et al [42] observed a strong enrichment of predicted
targetsinmRNAsassociatedwithFMRPinmammals.FMRP
may thus be a key determinant of miRNA:mRNA speciﬁcity.
This is consistent with the hypothesis that miRNAs act as
sequence-speciﬁc adaptors in the interaction of RNPs with
translationally regulated mRNAs [42]. This interaction may
be dictated, on the one hand, by the nucleotide sequence of
the miRNA and, on the other hand, by the presence of G
quartet structures [55] and/or kissing complex motifs [56]
in the mRNA. Therefore, it may not be a coincidence that
the FMR1 gene is highly conserved among vertebrates [27],
where mRNAs are primarily subjected to miRNP-induced
translation repression.
A MOLECULAR BASIS OF THE FRAGILE X SYNDROME?
The biochemical properties of FMRP make it a prime can-
didate for a role in mediating and relieving miRNA-guided
translational repression. We hypothesize that the absence of
FMRP expression may result in suboptimal miRNA assem-
bly on, and/or disassembly from, their natural mRNA tar-
gets, leading to a perturbed protein expression proﬁle (see
Figure 3). This may be expected given the requirement of
FMRP for eﬃcient small RNA-guided gene regulation [41].
The FMRP paralog fragile X-related protein 1 (FXR1P)
exhibited miRNA annealing and strand exchange prop-
erties similar to FMRP [41] .T h e s ed a t as u g g e s tac o n -
served function for fragile X proteins in RNA silencing and
open the possibility that FXR1P may partly complement or
compensate for the absence or loss of FMRP expression (see
Figure 2).
The next challenge will be to ascertain the ability of
FMRP toassembleand exchangemiRNA strandsin a cellular
context.Infact,severaladditionalissuesneedtobeaddressed
in order to validate the proposed hypothesis. For instance,
are these properties of FMRP preserved within miRNPs in
vivo? What are the cellular proteins and/or cofactors assist-
ing FMRP function in vivo? Is FMRP able to relieve miRNA-
guided mRNA repression? If so, what is the mechanistic of
that process, that is, the sequence of events, nature of the
components involved and/or signal(s) required? When and
where in the cell do these events take place? Elucidation of
the exact role and function of FMRP in miRNA-guided gene
regulation may hold key to determining the molecular ba-
sis of the fragile X syndrome and establishing a causal link
between dysfunction of the RNA-silencing machinery and a
human genetic disease.
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